Department of Defense Prostate Cancer Research Program Clinical Trial Award

The summary for the Department of Defense Prostate Cancer Research Program Clinical Trial Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

Department of Defense Prostate Cancer Research Program Clinical Trial Award: The Prostate Cancer Research Program (PCRP) Clinical Trial Award supports rapid execution of Phase I, Phase I/II, or Phase II clinical trials of novel interventions (e.g., drugs, biologics, and devices) with the potential to have a significant impact on prostate cancer prevention, detection, diagnosis, or treatment. Exploratory clinical trials may be submitted, but they must be accompanied by a Phase I clinical trial. Principal Investigators (PIs) must clearly specify in their proposals which type of clinical trial, Phase I, Phase I/II, or Phase II, is being proposed. Please refer to http://www.clinicaltrials.gov/ for definitions and descriptions of each type of clinical trial. Each proposal should contain only one clinical trial. PIs also are encouraged to pursue correlative studies. PIs conducting correlative studies must describe in detail the study aims, procedures or methods, and plans for data management and analysis, including an appropriately powered statistical plan.